Gambia vs Mali: The number of people with susceptibility test result for rifampicin
Gambia
1,175
in 2021
Mali
1,234
in 2021
Gambia rank
62nd
Mali rank
61st
The number of people with susceptibility test result for rifampicin over time
- Gambia
- Mali
How they compare
Mali currently reports 1,234 against 1,175 in Gambia, a difference of 59.
That makes Mali's figure about 1.1 times Gambia's.
Across all 5 years both countries report, Mali has been ahead every year.
Gambia ranks 62nd and Mali ranks 61st of 155 countries.
Mali has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gambia | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1 | 141 | 140 | Mali |
| 2020s | 646 | 1,823 | 1,177 | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Gambia or Mali?
- Mali, at 1,234 against 1,175 in Gambia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Gambia and Mali?
- 59, with Mali ahead.
- How many years of comparable data are there for Gambia and Mali?
- 5 years are reported by both, from 2017 to 2021.
- How do Gambia and Mali rank globally for the number of people with susceptibility test result for rifampicin?
- Gambia ranks 62nd and Mali ranks 61st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.